Andrew Finch Speaks at GCR Live: Global Merger Control 2026
October 26, 2026
On October 22, 2026, Cravath partner Andrew C. Finch participated in the Global Competition Review Live: Global Merger Control 2026 conference, which was held from October 22‑23 in Brussels, Belgium. The conference brought together practitioners from across Europe and further afield, including private practice lawyers, government representatives and in‑house counsel, to debate and analyze the latest major developments in merger control. Andrew conducted a fireside chat with Federal Trade Commission Chairman Andrew Ferguson.
Related Practices & Industries
Speakers
- Photo
-
-
J.D., 1997, University of Chicago Law SchoolHigh Honors
-
M.A., 1994, University of California, Los Angeles
-
B.A., 1991, University of California, BerkeleyHigh honors, Phi Beta Kappa
- New York
- California
- District of Columbia
Education
Admitted In
Related News & Insights
Deals & Cases
October 20, 2026
Neurotech’s Acquisition by Alcon
On October 20, 2026, Alcon, a global leader in eye care, announced it has acquired Neurotech Pharmaceuticals, Inc. (“Neurotech”), a company focused on developing innovative cell therapies for chronic and neurodegenerative eye diseases, for $550 million. Alcon may be required to make additional contingent payments, including upon the achievement of commercial milestones. This acquisition expands Alcon's retina portfolio with ENCELTO™, the first and only U.S. FDA-approved treatment for adults with idiopathic Macular Telangiectasia Type 2 (“MacTel”), a rare, progressive retinal disease that leads to irreversible central vision loss that has historically had no approved treatment options. Cravath represented Neurotech in connection with the transaction.
Deals & Cases
February 28, 2026
Paramount’s $110 Billion Acquisition of Warner Bros. Discovery, Inc.
On February 27, 2026, Paramount Skydance Corporation (“Paramount”) and Warner Bros. Discovery, Inc. ("WBD") announced they have entered into a definitive merger agreement under which Paramount will acquire WBD. Under the terms of the agreement, Paramount will pay $31.00 per share in cash for all outstanding shares of WBD. The transaction values WBD at an enterprise value of $110 billion, and has been unanimously approved by the Boards of Directors of both companies. Cravath is representing Paramount in connection with the transaction.
Deals & Cases
February 02, 2026
Elsevier Wins Dismissal with Prejudice of Putative Antitrust Class Action
On January 30, 2026, the United States District Court for the Eastern District of New York granted with prejudice Cravath client Elsevier B.V.’s (“Elsevier”) motion to dismiss an antitrust lawsuit alleging an international conspiracy to fix prices and suppress competition in peer‑reviewed scholarly journal publishing.
Deals & Cases
December 09, 2025
Paramount’s $108.4 Billion All‑Cash Tender Offer to Acquire Warner Bros. Discovery, Inc.
On December 8, 2025, Paramount, a Skydance Corporation (“Paramount”), announced it has commenced an all-cash tender offer to acquire all of the outstanding shares of Warner Bros. Discovery, Inc. (“WBD”) for $30.00 per share in cash, equating to an enterprise value of $108.4 billion. Paramount’s proposed transaction is for the entirety of WBD, including the Global Networks segment. Cravath is representing Paramount in connection with the transaction.
